Epidural during/Post spine surgery gives better outcomes

Epidural during/Post spine surgery gives better outcomes
In patients undergoing reconstructive spine surgery, combined epidural and general anesthesia results in better pain control and other outcomes compared with general anesthesia plus narcotics, according to a study published in the July 1 issue of Spine.

(HealthDay)—In patients undergoing reconstructive spine surgery, combined epidural and general anesthesia results in better pain control and other outcomes compared with general anesthesia plus narcotics, according to a study published in the July 1 issue of Spine.

Anna A. Ezhevskaya, M.D., from the Nizhny Novgorod Research Institute of Traumatology and Orthopedics in Russia, and colleagues randomly assigned 85 patients undergoing reconstructive to epidural anesthesia and endotracheal anesthesia with sevoflurane during surgery and continuous epidural analgesia with ropivacaine, fentanyl, and epinephrine after surgery, or general anesthesia with sevoflurane and fentanyl and systemically administered opioids after surgery.

The researchers found that the group receiving epidural anesthesia experienced significantly less pain and nausea, earlier mobility, higher satisfaction, and significantly less introperative and postoperative blood loss. The epidural group also had lower levels of glucose, cortisol, and -1?, -6, and -10 postoperatively.

"Combined epidural/general anesthesia and postoperative epidural analgesia produced better pain control, less bleeding, and a lower surgical than general anesthesia with postoperative systemically administered narcotic analgesia," Ezhevskaya and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Anesthesia regimen linked to post-orthognathic op pain

date Jul 31, 2012

(HealthDay) -- Patients undergoing orthognathic maxillofacial surgery experience more pain postoperatively if they receive anesthesia with propofol and remifentanil versus inhalational agents and longer-acting ...

Recommended for you

Drug and device firms paid $6.5B to care providers

date Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.